Horiuchi, I.; Horiuchi, A.; Horiuchi, K.; Watanabe, S.; Terashima, T.; Sugimoto, K.
Geboes Histopathology Score Grade 3 Subclassification Predicts Treatment Response in Active Ulcerative Colitis. J. Clin. Med. 2025, 14, 7214.
https://doi.org/10.3390/jcm14207214
AMA Style
Horiuchi I, Horiuchi A, Horiuchi K, Watanabe S, Terashima T, Sugimoto K.
Geboes Histopathology Score Grade 3 Subclassification Predicts Treatment Response in Active Ulcerative Colitis. Journal of Clinical Medicine. 2025; 14(20):7214.
https://doi.org/10.3390/jcm14207214
Chicago/Turabian Style
Horiuchi, Ichitaro, Akira Horiuchi, Kaori Horiuchi, Shun Watanabe, Tsuyoshi Terashima, and Ken Sugimoto.
2025. "Geboes Histopathology Score Grade 3 Subclassification Predicts Treatment Response in Active Ulcerative Colitis" Journal of Clinical Medicine 14, no. 20: 7214.
https://doi.org/10.3390/jcm14207214
APA Style
Horiuchi, I., Horiuchi, A., Horiuchi, K., Watanabe, S., Terashima, T., & Sugimoto, K.
(2025). Geboes Histopathology Score Grade 3 Subclassification Predicts Treatment Response in Active Ulcerative Colitis. Journal of Clinical Medicine, 14(20), 7214.
https://doi.org/10.3390/jcm14207214
